{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:33:24Z","timestamp":1760150004982,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":5796,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.jpainsymman.2003.12.008","type":"journal-article","created":{"date-parts":[[2004,3,5]],"date-time":"2004-03-05T06:38:47Z","timestamp":1078468727000},"page":"194-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of thioridazine in palliative care patients with troublesome sweating"],"prefix":"10.1016","volume":"27","author":[{"given":"Syed Qamar","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB1","series-title":"Oxford textbook of palliative medicine","first-page":"636","article-title":"Management of skin problems. Sweating","author":"Mortimer","year":"1998"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0885-3924(94)90174-0","article-title":"Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic","volume":"6","author":"Grond","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/082585979701300105","article-title":"Descriptive epidemiology of sweating in a hospice population","volume":"13","author":"Quigley","year":"1997","journal-title":"J Palliative Care"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2796.1990.tb00262.x","article-title":"A randomized trial of the effect of three non-steroidal anti-inflammatory agents in ameliorating cancer-induced fever","volume":"228","author":"Tsavaris","year":"1990","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0885-3924(03)00141-6","article-title":"Flushing and sweating in an advanced breast cancer patient relieved by olanzapine","volume":"25","author":"Zyclicz","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB6","first-page":"78","article-title":"Use of low dose thioridazine to control sweating in advanced cancer","volume":"10","author":"Regnard","year":"1996","journal-title":"Pall Medicine"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB7","first-page":"266","article-title":"Thioridazine in the management of cancer related sweating","volume":"15","author":"Cowap","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/15563659509017984","article-title":"Cardiotoxicity more common in thioridazine overdose than with other neuroleptics","volume":"33","author":"Buckley","year":"1995","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB9","unstructured":"Antipsychotic drugs. Section 4.2.1. British National Formulary 46; British Medical Association and the Royal Pharmaceutical Society of Great Britain. London, 2003."},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and antipsychotic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2003.12.008_BIB11","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0885-3924(03)00313-0","article-title":"Prolongation of QT interval in palliative care patients","volume":"26","author":"Walker","year":"2003","journal-title":"J Pain Symptom Manage"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392403005098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392403005098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:54:10Z","timestamp":1760129650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392403005098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0885392403005098"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.12.008","relation":{},"ISSN":["0885-3924"],"issn-type":[{"type":"print","value":"0885-3924"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of thioridazine in palliative care patients with troublesome sweating","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}